ATE422900T1 - Verfahren zur herstellung eines azellulären impfstoffes der bordetella pertussis antigene enthält - Google Patents

Verfahren zur herstellung eines azellulären impfstoffes der bordetella pertussis antigene enthält

Info

Publication number
ATE422900T1
ATE422900T1 AT04018329T AT04018329T ATE422900T1 AT E422900 T1 ATE422900 T1 AT E422900T1 AT 04018329 T AT04018329 T AT 04018329T AT 04018329 T AT04018329 T AT 04018329T AT E422900 T1 ATE422900 T1 AT E422900T1
Authority
AT
Austria
Prior art keywords
producing
bordetella pertussis
vaccine containing
pertussis antigens
cellular vaccine
Prior art date
Application number
AT04018329T
Other languages
English (en)
Inventor
Pavel Novotny
Original Assignee
Medeva Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10656410&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE422900(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Medeva Bv filed Critical Medeva Bv
Application granted granted Critical
Publication of ATE422900T1 publication Critical patent/ATE422900T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/099—Bordetella
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Electrical Discharge Machining, Electrochemical Machining, And Combined Machining (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Liquid Crystal Substances (AREA)
AT04018329T 1989-05-08 1990-04-26 Verfahren zur herstellung eines azellulären impfstoffes der bordetella pertussis antigene enthält ATE422900T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB898910570A GB8910570D0 (en) 1989-05-08 1989-05-08 Acellular vaccine

Publications (1)

Publication Number Publication Date
ATE422900T1 true ATE422900T1 (de) 2009-03-15

Family

ID=10656410

Family Applications (3)

Application Number Title Priority Date Filing Date
AT04018329T ATE422900T1 (de) 1989-05-08 1990-04-26 Verfahren zur herstellung eines azellulären impfstoffes der bordetella pertussis antigene enthält
AT90907222T ATE147271T1 (de) 1989-05-08 1990-04-26 Azellulärer impfstoff
AT96112324T ATE276759T1 (de) 1989-05-08 1990-04-26 Azellulärer impfstoff

Family Applications After (2)

Application Number Title Priority Date Filing Date
AT90907222T ATE147271T1 (de) 1989-05-08 1990-04-26 Azellulärer impfstoff
AT96112324T ATE276759T1 (de) 1989-05-08 1990-04-26 Azellulärer impfstoff

Country Status (12)

Country Link
US (1) US7479283B1 (de)
EP (3) EP1666057B1 (de)
JP (2) JP3281369B2 (de)
AT (3) ATE422900T1 (de)
DE (14) DE122005000016I1 (de)
DK (3) DK0747058T3 (de)
ES (3) ES2230555T3 (de)
FR (1) FR09C0033I1 (de)
GB (1) GB8910570D0 (de)
LU (15) LU90204I2 (de)
NL (13) NL980007I1 (de)
WO (1) WO1990013313A1 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8412207D0 (en) * 1984-05-12 1984-06-20 Wellcome Found Antigenic preparations
GB8910570D0 (en) 1989-05-08 1989-06-21 Wellcome Found Acellular vaccine
EP0484621A3 (en) * 1990-07-11 1992-08-26 American Cyanamid Company Efficacious vaccines against bordetella pertussis comprising a combination of individually purified pertussis antigens
GB9021004D0 (en) * 1990-09-27 1990-11-07 Wellcome Found Acellular vaccines
GB9209118D0 (en) * 1992-04-28 1992-06-10 Sb 120 Amsterdam Bv Vaccine compositions
FR2754543B1 (fr) * 1996-10-11 1998-12-31 Pasteur Institut Souche de bordetella deficiente dans la production de toxine et exprimant une proteine hydride, liposomes comprenant de la fha et leurs utilisations comme vaccins, et utilisation de la fha pour stimuler les reponses immunitaires
US7022522B2 (en) 1998-11-13 2006-04-04 Limin Guan Macroporous polymer scaffold containing calcium phosphate particles
RU2148412C1 (ru) * 1999-08-06 2000-05-10 Москаленко Екатерина Петровна Способ получения протективного коклюшного антигена
AU2004277342B2 (en) * 2003-10-02 2010-12-16 Glaxosmithkline Biologicals S.A. Pertussis antigens and use thereof in vaccination
WO2009094006A2 (en) * 2007-10-25 2009-07-30 Wake Forest University Health Sciences Bordetella outer-membrane protein antigens and methods of making and using the same
US20110001080A1 (en) 2008-03-07 2011-01-06 Arkema Inc. Stable formulated systems with chloro-3,3,3-trifluoropropene
GB201105981D0 (en) 2011-04-08 2011-05-18 Glaxosmithkline Biolog Sa Novel process
BR112015021523A8 (pt) 2013-03-08 2021-06-29 Crucell Holland Bv composição de uma vacina contra a tosse convulsa acelular, e, usos da composição e de antígenos da bordetella pertussis
RU2662968C2 (ru) 2013-09-08 2018-07-31 Пфайзер Инк. Иммуногенная композиция против neisseria meningitidis (варианты)
KR20190049940A (ko) 2015-02-19 2019-05-09 화이자 인코포레이티드 나이세리아 메닌지티디스 조성물 및 그의 방법

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2047886A1 (en) 1969-06-30 1971-03-19 Merieux Inst Non-toxic anti-whooping cough vaccine
DE3176347D1 (en) 1980-06-27 1987-09-17 Ciba Geigy Ag Synergistic agents and method for the selective control of weeds, particularly in cereals and soybeans
JPS5750925A (en) 1980-09-12 1982-03-25 Takeda Chem Ind Ltd Preparation of pertussis toxoid
JPS58222032A (ja) 1982-06-18 1983-12-23 Teijin Ltd 百日咳毒素のサブユニツト蛋白
US5237052A (en) * 1984-05-12 1993-08-17 Burroughs Wellcome Company Antigenic preparations and isolation of such preparations
GB8412207D0 (en) 1984-05-12 1984-06-20 Wellcome Found Antigenic preparations
JPS6176422A (ja) * 1984-09-22 1986-04-18 Chemo Sero Therapeut Res Inst 百日ぜきコンポ−ネントワクチンおよび百日ぜき・ジフテリア・破傷風混合ワクチンの製造方法
FR2590483B1 (fr) 1985-11-22 1988-12-09 Pasteur Institut Antigenes purifies ayant des proprietes vaccinantes contre b. pertussis, moyens notamment adns recombinants pour les produire et compositions de vaccins les contenant
GB8601279D0 (en) * 1986-01-20 1986-02-26 Public Health Lab Service Purification of pertussis antigens
EP0267498B1 (de) * 1986-11-11 1993-01-27 Siemens Aktiengesellschaft Flusskompensierter Stromwandler
FR2606789B1 (fr) 1986-11-17 1991-05-31 Pasteur Institut Preparations d'adenylate cyclase purifiees, procede d'obtention de ces preparations et leurs applications biologiques
EP0267998A1 (de) * 1986-11-17 1988-05-25 Institut Pasteur Mittel zur Unterstützung gegen Infektion und Vergiftung von Bordetella
US5358868A (en) * 1987-11-24 1994-10-25 Connaught Laboratories Limited Genetic detoxification of pertussis toxin
GB8807860D0 (en) 1988-04-05 1988-05-05 Connaught Lab Pertussis vaccine
US5101014A (en) * 1989-02-10 1992-03-31 United States Of America Process for the purification of a 69,000 da outer membrane protein of Bordetella pertussis
US5162223A (en) * 1989-02-17 1992-11-10 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Resources Hybridomas and resulting monoclonal antibodies directed against antigens of Bordetella pertussis
GB8910570D0 (en) 1989-05-08 1989-06-21 Wellcome Found Acellular vaccine
US5276142A (en) * 1989-12-11 1994-01-04 American Cyanamid Company Process for purification of a 69000 dalton antigenic protein from Bordetella pertussis
GB9007416D0 (en) 1990-04-02 1990-05-30 Wellcome Found Expression of heterologous protein in yeast
GB9007657D0 (en) 1990-04-04 1990-05-30 Connaught Lab Purification of a pertussis outer membrane protein(omp69)
IT1248735B (it) 1990-06-21 1995-01-26 Sclavo Spa Vaccini acellulari contro la pertosse
EP0484621A3 (en) 1990-07-11 1992-08-26 American Cyanamid Company Efficacious vaccines against bordetella pertussis comprising a combination of individually purified pertussis antigens
DE69511392T2 (de) 1994-04-28 2000-03-23 Takeda Chemical Industries, Ltd. Verfahren zur trennung von protektiven verbindungen aus bordetella pertussis
US5972225A (en) * 1996-05-07 1999-10-26 Cook Imaging Corporation Process for remediating endotoxin-contaminated bulk non-ionic contrast media

Also Published As

Publication number Publication date
EP0471726A1 (de) 1992-02-26
NL300184I1 (nl) 2005-06-01
JP3281369B2 (ja) 2002-05-13
NL980007I1 (nl) 1998-04-01
EP1666057A3 (de) 2008-06-04
NL300400I1 (en) 2009-10-01
NL300183I1 (nl) 2005-06-01
DK0471726T4 (da) 2008-09-15
GB8910570D0 (en) 1989-06-21
FR09C0033I1 (de) 2009-09-25
EP0747058A1 (de) 1996-12-11
LU91592I2 (fr) 2009-10-12
NL300189I1 (nl) 2005-06-01
DE69029656T2 (de) 1997-04-24
LU91154I2 (fr) 2005-06-23
LU91595I2 (fr) 2009-10-12
NL300185I1 (nl) 2005-06-01
DE122005000014I1 (de) 2005-06-23
ATE276759T1 (de) 2004-10-15
LU91149I2 (fr) 2005-06-23
DE122005000016I1 (de) 2005-06-23
LU90204I2 (fr) 1998-04-06
DE122009000044I1 (de) 2009-11-05
LU91597I2 (fr) 2009-10-12
DE69029656T3 (de) 2009-06-04
DE122009000042I1 (de) 2009-11-05
LU91596I2 (fr) 2009-10-12
NL300404I1 (en) 2009-10-01
DK1666057T3 (da) 2009-06-08
LU91593I2 (fr) 2009-10-12
DE122005000019I1 (de) 2005-06-23
JP2002226397A (ja) 2002-08-14
DE122009000043I1 (de) 2009-11-05
EP1666057B1 (de) 2009-02-18
NL300403I1 (en) 2009-10-01
LU91155I2 (fr) 2005-06-23
ATE147271T1 (de) 1997-01-15
DK0747058T3 (da) 2005-01-10
DK0471726T3 (da) 1997-03-03
ES2095874T5 (es) 2008-11-01
LU91151I2 (fr) 2005-06-23
DE122009000041I1 (de) 2009-11-05
LU91150I2 (fr) 2005-06-23
NL300188I1 (nl) 2005-06-01
EP0747058B1 (de) 2004-09-22
DE122005000018I1 (de) 2005-06-23
LU91153I2 (fr) 2005-06-23
DE122005000020I1 (de) 2005-06-23
LU91591I2 (fr) 2009-10-12
EP0471726B2 (de) 2008-05-14
NL300401I1 (en) 2009-10-01
EP0471726B1 (de) 1997-01-08
US7479283B1 (en) 2009-01-20
DE122005000017I1 (de) 2005-06-23
NL300402I1 (en) 2009-10-01
DE69034166D1 (de) 2004-10-28
JPH04505158A (ja) 1992-09-10
DE69034264D1 (de) 2009-04-02
NL300186I1 (nl) 2005-06-01
DE69034166T2 (de) 2005-08-04
LU91594I2 (fr) 2009-10-12
ES2322352T3 (es) 2009-06-19
LU91152I2 (fr) 2005-06-23
EP1666057A2 (de) 2006-06-07
ES2230555T3 (es) 2005-05-01
DE122005000015I1 (de) 2005-11-24
ES2095874T3 (es) 1997-03-01
WO1990013313A1 (en) 1990-11-15
DE69029656D1 (de) 1997-02-20
NL300187I1 (nl) 2005-06-01

Similar Documents

Publication Publication Date Title
NL300403I1 (en) Method and manufacture of an acellular vaccine comprising Bordetella pertussis antigens
NL980006I1 (nl) Antigeen-preparaten en isolering van dergelijke preparaten.
ATE159758T1 (de) Azelluläre impfstoffe